Sukhjit Starch & Chemicals: Q3 FY26 Unaudited Results Released
Sukhjit Starch & Chemicals reported unaudited Q3 FY26 results. Standalone revenue was ₹345.25 crore, with net profit ₹4.04 crore. Consolidated revenue stood at ₹348.71 crore, with net profit ₹3.13 crore. Nine-month standalone revenue reached ₹1001.89 crore and consolidated revenue ₹1040.35 crore.
Financial results are material information for investors and directly impact stock valuation, hence a medium impact.
The announcement reports financial results without significant positive or negative deviations from expectations, leading to a neutral sentiment.
Sukhjit Starch & Chemicals Limited has published its unaudited financial results for the quarter and nine months ended December 31, 2025. The company reported its standalone total income from operations at ₹345.25 crore for the quarter and ₹1001.89 crore for the nine-month period. Net profit before tax stood at ₹5.34 crore for the quarter and ₹15.71 crore for the nine months. After tax, the net profit was ₹4.04 crore for the quarter and ₹10.80 crore for the nine months.
On a consolidated basis, the total income from operations was ₹348.71 crore for the quarter and ₹1040.35 crore for the nine months ended December 31, 2025. The consolidated net profit before tax was ₹4.18 crore for the quarter and ₹15.11 crore for the nine months. Post-tax, the consolidated net profit was ₹3.13 crore for the quarter and ₹10.78 crore for the nine months. The company's earnings per share (EPS) for the quarter were ₹1.29 on a standalone basis and ₹1.00 on a consolidated basis. For the nine-month period, standalone EPS was ₹3.46 and consolidated EPS was ₹3.45.
The results were published in the Financial Express and Jag Bani newspapers on February 13, 2026, and February 14, 2026, respectively. The detailed financial results are available on the websites of BSE and NSE, as well as the company's website.
What to do with a filing like this
Sukhjit Starch & Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Sukhjit Starch & Chemicals Limited. Read the original for the full detail.